Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

G A Amos Burke, Thomas G. Gross, MD PhD, Marta Pillon, Veronique Minard-colin, Raphael F Delgado, József Zsíros, Anne Uyttebroeck, Jean Michon, Catherine M. Bollard, MD FRACP, FRCPA, Monika Csoka, Donald A Barkauskas, Keith Wheatley, DPhil, Anne Aupérin, Catherine Patte

Blood (2017) 130 (Supplement 1): 4124.

https://doi.org/10.1182/blood.V130.Suppl_1.4124.4124

Published: 2017

Journal Articles

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

Mary Gerrard, Ian M. Waxman, Richard Sposto, Anne Auperin, Sherrie L. Perkins, Stanton Goldman, Lauren Harrison, Ross Pinkerton, Keith McCarthy, Martine Raphael, Catherine Patte, Mitchell S. Cairo

Blood (2013) 121 (2): 278–285.

https://doi.org/10.1182/blood-2012-04-422709

Published: 2013

Includes: Supplemental data

Journal Articles

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Mitchell S. Cairo, Mary Gerrard, Richard Sposto, Anne Auperin, C. Ross Pinkerton, Jean Michon, Claire Weston, Sherrie L. Perkins, Martine Raphael, Keith McCarthy, Catherine Patte, on behalf of the FAB LMB96 International Study Committee

Blood (2006) 109 (7): 2736–2743.

https://doi.org/10.1182/blood-2006-07-036665

Published: 2006

Journal Articles

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Catherine Patte, Anne Auperin, Mary Gerrard, Jean Michon, Ross Pinkerton, Richard Sposto, Claire Weston, Martine Raphael, Sherrie L. Perkins, Keith McCarthy, Mitchell S. Cairo, for the FAB/LMB96 International Study Committee

Blood (2006) 109 (7): 2773–2780.

https://doi.org/10.1182/blood-2006-07-036673

Published: 2006

Journal Articles

Excellent Results in Children and Adolescents with Isolated Mature B-Acute Lymphoblastic Leukemia (B-ALL) (Burkitt): Report from the French-American-British (FAB) International LMB Study FAB/LMB96.

Stan Goldman, Mary Gerrard, Richard Sposto, Ginny Davenport, Anne Auperin, Ross Pinkerton, Jean Michon, Claire Weston, Sherrie L. Perkins, Martine Raphael, Keith McCarthy, Catherine Patte, Mitchell S. Cairo

Blood (2005) 106 (11): 234.

https://doi.org/10.1182/blood.V106.11.234.234

Published: 2005

Journal Articles

Treatment of Childhood T Cell Lymphoblastic Lymphoma (TLL), Results of the SFOP LMT96.

Christophe Bergeron, MD, David Perol, MD, Helene Pacquement, MD, Yves Perel, MD, Carole Coze, MD, Virginie Gandemer, MD, Jean P. Vannier, MD, Francois Mechinaud, MD, Claudine Schmitt, MD, Guy Leverger, MD, Andre Baruchel, MD, Catherine Patte, MD

Blood (2005) 106 (11): 3326.

https://doi.org/10.1182/blood.V106.11.3326.3326

Published: 2005

Journal Articles

SFCE (Societe Francaise des Cancers de l’Enfant) Recommendations for the Management of Tumor Lysis Syndrome (TLS): A Validation Survey.

Yves Bertrand, Anne Auvrignon, MD, Brigitte Nelken, MD, Valérie Mialoux, MD, Francoise Mechinaud, MD, Catherine Patte, MD, Dominique Plantaz, MD, Nathalie Le Guyader, MD, Marisol Urbieta, MD, Yves Perel, Andre Baruchel9, Guy Leverger

Blood (2005) 106 (11): 3122.

https://doi.org/10.1182/blood.V106.11.3122.3122

Published: 2005

Journal Articles

In Pediatric Mature B-Cell Non Hodgkin Lymphoma (NHL), Complex Karyotype or del(13q) Are Linked Prognostic Factors in Burkitt Lymphoma (BL) While 8q24/c-myc Rearrangement Is Associated with a Strong Adverse Effect in Diffuse Large B-Cell Lymphoma (DLBCL).

Hélène A. Poirel, Nyla A. Heerema, John Swansbury, Anne Aupérin, Erika Launay, Warren G. Sanger, Polly Talley, Martine Raphael, Sherrie Perkins, Keith McCarthy, Richard Sposto, Claire Weston, Mary Gerrard, Mitch S. Cairo, Alain Bernheim, Catherine Patte

Blood (2005) 106 (11): 1905.

https://doi.org/10.1182/blood.V106.11.1905.1905

Published: 2005

Journal Articles

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

Catherine Patte, Anne Auperin, Jean Michon, Henk Behrendt, Guy Leverger, Didier Frappaz, Patrick Lutz, Carole Coze, Yves Perel, Martine Raphaël, Marie-Josée Terrier-Lacombe

Blood (2001) 97 (11): 3370–3379.

https://doi.org/10.1182/blood.V97.11.3370

Published: 2001

Journal Articles

High-Dose Chemotherapy With Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry

Ruth Ladenstein, Rachel Pearce, Olivier Hartmann, Catherine Patte, Tony Goldstone, Thierry Philip

Blood (1997) 90 (8): 2921–2930.

https://doi.org/10.1182/blood.V90.8.2921

Published: 1997

NARROW

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Excellent Results in Children and Adolescents with Isolated Mature B-Acute Lymphoblastic Leukemia (B-ALL) (Burkitt): Report from the French-American-British (FAB) International LMB Study FAB/LMB96.

Treatment of Childhood T Cell Lymphoblastic Lymphoma (TLL), Results of the SFOP LMT96.

SFCE (Societe Francaise des Cancers de l’Enfant) Recommendations for the Management of Tumor Lysis Syndrome (TLS): A Validation Survey.

In Pediatric Mature B-Cell Non Hodgkin Lymphoma (NHL), Complex Karyotype or del(13q) Are Linked Prognostic Factors in Burkitt Lymphoma (BL) While 8q24/c-myc Rearrangement Is Associated with a Strong Adverse Effect in Diffuse Large B-Cell Lymphoma (DLBCL).

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

High-Dose Chemotherapy With Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only